My feedback

2 results found

1. QRISK3 Score

   9 votes

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   1 comment  ·  Formula Suggestions » New Formulas  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close
   An error occurred while saving the comment
   Anonymous commented  ·  Jun 27, 2017  ·  Edit…  ·  Delete…

   Apparently affords a more thorough chronic risk assessment and had been recent shown to be clinically useful

   Save Submitting...

2. HERDOO / HERDOO2

   64 votes

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   5 comments  ·  Formula Suggestions » New Formulas  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close
   An error occurred while saving the comment
   Anonymous commented  ·  Apr 25, 2017  ·  Edit…  ·  Delete…

   Predicting recurrence likelihood after unprovoked VTE in women.

   Rodger MA et al. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: Multinational prospective cohort management study. BMJ 2017 Mar 17; 356:j1065. (http://dx.doi.org/10.1136/bmj.j1065)
   Abstract/FREE Full Text

   Save Submitting...
   Anonymous supported this idea  ·  Apr 25, 2017